Dedomenico Receives Award

SEATTLE, Wash. (May 2, 2012) –California owner and breeder Dr. Mark Dedomenico, renowned cardiovascular surgeon and Northwest native, just received the Golden Heart Honoree Award for 2012, the annual tribute for outstanding contributions to the treatment and prevention of cardiovascular disease by the American Heart Association. 

The Golden Heart Honoree Award ceremony acknowledged Dr. Dedomenico’s world-renowned career as a heart surgeon, researcher and innovator. 

Prior to his outstanding achievements as an equine breeder and medical researcher in racehorse rehabilitation, Dr. Dedomenico pioneered the development of Coronary-By-Pass Surgery, the Guided Flow Aortic Valve and the Bard Arterial Prosthesis.   Dr. Dedomenico’s work has affected the lives of millions of cardiac patients around the planet who would not have otherwise benefitted from advanced coronary technology.  His efforts in cardiac research and funding have been tied closely with the Hope Heart Institute of Seattle, formerly known as The Reconstructive Cardiovascular Research Center.

Dr. Dedomenico’s successes with health protocols also led him to dedicate some of his research to equine health, since he and his family have been part of the thoroughbred horse racing industry for decades.  His passion for horses and their well-being led him to construct the world’s foremost breeding and thoroughbred training center, located in Redmond, Washington. 

Dr. Dedomenico’s complex, The Pegasus Thoroughbred Rehabilitation and Training Center, hosts only the finest state-of-the-art equipment for equine recuperation, including a equine swimming pool, underwater treadmill, hyperbaric chamber, vibration platform, eurosizers, a 5 furlong polytrack, and the finest surgery and medically advanced rehabilitation techniques in the world.

In conjunction with Dr. Wayne McIwrath of Colorado State University, the leading equine surgeon in the word today, Dr. Dedomenico has researched equine health for years with three projects underway: the halting of osteoarthritis -cartilage healing of the knee – and use of platelet rich plasma and stem cells to repair injured tendons.  The results of this research will also transfer to humans.